Johnson & Johnson vs M&T Bank Corporation — how do they compare? Johnson & Johnson trades at $258.75 (market cap $626.09B), while M&T Bank Corporation trades at $251.93 (market cap $36.42B). The key difference: Johnson & Johnson is far larger — about 17.2× M&T Bank Corporation's market cap, and M&T Bank Corporation pays the higher dividend (2.38%). Which is the better fit depends on your goals.
| JNJ | MTB | |
|---|---|---|
Market Cap | $626.09B | $36.42B |
Volume | 6,156,228 | — |
Sector | Health | Financials |
52-Week High | $267.24 | $254.04 |
52-Week Low | $172.78 | $178.63 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | 2.38% |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →